scholarly journals Assessing the dynamic of agri-food export trends before and after the EU Eastern Enlargement

2018 ◽  
pp. 44-57 ◽  
Author(s):  
Antonino Galati ◽  
Marcella Giacomarra ◽  
Maria Crescimanno
Keyword(s):  
Eastern Enlargement ◽  
Before And After ◽  
Eu Eastern Enlargement ◽  
The Eu

Dynamik der realwirtschaftlichen Integration am Beispiel der EU-Osterweiterung / On the Dynamics of Economic Integration: The Case of the EU Eastern Enlargement

1999 ◽  
Vol 218 (3-4) ◽  
Author(s):  
Lucas Bretschger
Keyword(s):  
Economic Integration ◽  
Eastern Enlargement ◽  
Eu Eastern Enlargement ◽  
The Eu

ZusammenfassungIn diesem Beitrag werden die Auswirkungen einer wirtschaftlichen Integration auf das langfristige Wachstum analysiert. Dabei wird von international unterschiedlichen Faktorausstattungen, einer unvollständigen Wissensdiffusion und der Existenz von Umweltproblemen ausgegangen. Als Resultat einer Integration ergibt sich, daß eine für die langfristige Dynamik ungünstige Reallokation der Ressourcen zwischen den Wirtschaftssektoren nicht auszuschließen ist. Dies trifft vor allem dann zu, wenn die Integrationspartner über wenig qualifizierte Arbeit verfügen, die internationale Wissensdiffusion gering ist sowie die Substitutionsmöglichkeiten zwischen den verschiedenen Arbeitsinputs sowie zwischen den natürlichen Ressourcen und dem Faktor Wissen gering sind. Diese Fälle werden am Beispiel der EU-Osterweiterung diskutiert.

Financial context of ceec process of privatization and restructuring (czech republic, poland, hungary)

1998 ◽  
Vol 7 (2) ◽  
Author(s):  
Petr Chvojka
Keyword(s):  
Czech Republic ◽  
Market Economy ◽  
Homogeneous Group ◽  
Eastern Enlargement ◽  
The Czech Republic ◽  
Common Features ◽  
Low Level ◽  
Successful Transition ◽  
Eu Eastern Enlargement ◽  
The Eu

As EU Eastern enlargement draws nearer, CEE countries - especially those with the best chance to become EU members in the first group - have to get prepared for the EU environment, where they will be exposed to new competitive pressures. They have to increase their performance and overcome their low level of competitiveness, existing in spite of their recent relatively successful transition from command to market economy. Even though they are not a homogeneous group of states, at minimum those of them, the application of which for joining EU are dealt with, show despite the existing differences certain common features of their hitherto transformation (including restructuring) development (we take into account the Czech Republic, Hungary and Poland).

scholarly journals 1918 barrier on the road to the membership of the European Union

2007 ◽  
pp. 11-34
Author(s):  
Miroslav Jovanovic
Keyword(s):  
European Union ◽  
The European Union ◽  
Eastern Enlargement ◽  
Distant Future ◽  
The Road ◽  
The Government ◽  
On The Road ◽  
Constitutional System ◽  
Eu Eastern Enlargement ◽  
The Eu

The European Union (EU) and Serbia?s accession to this international organization in a relatively distant future are linked, in the eyes of the Serbian public, with numerous expectations, dilemmas, misunderstanding fears, joys and periodical manipulations. The topic is important, broad and complex, so there is a need for the basic and understandable explanations. While in Serbia this topic is one of the most important and high on the government?s agenda. In the EU and its member countries, it attracts almost no attention and is not a priority issue. Simply, the EU is concerned with much more important issues, such as its future constitutional system security, energy, globalization, unemployment, immigration, demographic problem (population ageing), monetary union, preservation of the single market and adjustment to the EU eastern enlargement of 2004 and 2007. After introduction to the advantages and problems relating to Serbia?s potential accession to the EU, the attention is turned to the issues that include geopolitical conditions for accession to the EU, legislation and functioning of the EU, as well as its budget. Effects of integration, the EU?s interest in Serbia and Serbia?s interest in the EU are presented before conclusions.

The Politics of EU Eastern Enlargement: Evidence from a Heckman Selection Model

2005 ◽  
Vol 36 (1) ◽  
pp. 17-38 ◽  
Author(s):  
THOMAS PLÜMPER ◽  
CHRISTINA J. SCHNEIDER ◽  
VERA E. TROEGER
Keyword(s):  
Selection Model ◽  
Policy Support ◽  
Reform Process ◽  
The European Union ◽  
Eastern Enlargement ◽  
Heckman Selection Model ◽  
Acquis Communautaire ◽  
Eu Eastern Enlargement ◽  
Heckman Selection ◽  
The Eu

The eastern enlargement of the European Union is a twofold process, in which governments of transition countries decide whether or not to apply for membership and in turn EU members decide whether or not to accept these applicants. The authors argue that the level of democracy and the extent of market reforms together determine the first decision, while the second decision is largely determined by the EU observing the reform process in applicant countries imposed by the acquis communautaire conditionality. The natural procedure to test this theory is a Heckman selection model. A Heckman specification with panel probit estimators in both stages is used. The data supports the argument that uncontested reforms signal the policy support of relevant political parties to the EUand increase the likelihood of joining the Union. The authors also test for specification errors and check the robustness of the findings.

scholarly journals PARE0007 PATIENT AND PUBLIC INVOLVEMENT IN CLINICAL TRIAL DESIGN

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1289.1-1290
Author(s):  
S. De Souza ◽  
R. Williams ◽  
E. Johansson ◽  
C. Zabalan ◽  
T. Esterine ◽  
...  
Keyword(s):  
At Risk ◽  
Lived Experience ◽  
Public Involvement ◽  
Clinical Trial Design ◽  
Patient And Public Involvement ◽  
Face To Face ◽  
Before And After ◽  
Extensive Consultation ◽  
New Perspective ◽  
The Eu

Background:Patient and public involvement (PPI) is gaining increasing recognition as important in ensuring research is relevant and acceptable to participants. Rheuma Tolerance for Cure (RTCure) is a 5 year international collaboration between academia and industry; focusing on earlier detection and prevention of rheumatoid arthritis (RA) through the use of immune-tolerising treatments.Objectives:To bring lived experience and insight into scientific discussions; and to evolve collaboration between lay representatives and academia/industry.Methods:9 Patient Research Partners (PRPs) from 5 European countries were recruited via the EULAR PARE Network and institutions within the RTCure Consortium (8 PRPs with RA and 1 ‘at risk’). They were asked to enter into a legal agreement with the Consortium. PRPs participated in teleconferences (TCs) and were invited to attend face-to-face (F2F) meetings at least annually. Requests for input/feedback were sent from researchers to PRPs via the project’s Patient Engagement Expert [SK].Results:PRP involvement has given researchers and industry partners a new perspective on patient priorities, and focused thought on the ethics of recruitment for and participation in clinical trials of people ‘at risk’ of developing RA. PRPs have helped define the target populations, given their thoughts on what types of treatments are acceptable to people ‘at risk’ and have aided the development of a survey (sent to EULAR PARE members) regarding the use of animal models in biomedical research. Positive informal feedback has been received from researchers and industry regarding the contribution of PRPs to the ongoing project (formal evaluation of PPI in RTCure will be carried out in 2020 and at the project end in 2022).Challenges:Legal agreements- Many PRPs refused to sign the Consortium’s complex PRP Agreement; feeling it unnecessary, incomprehensible and inequitable. After extensive consultation with various parties (including EULAR and the Innovative Medicines Initiative) no similar contract was found. Views for its requirement even varied between legal experts. After 2 years of intense discussion, a simple non-disclosure agreement was agreed upon. Ideally any contract, if required, should be approved prior to project onset.Meeting logistics- Other improvements identified were to locate the meeting venue and accommodation on the same site to minimise travel, and to make it easier for PRPs to take breaks when required. This also facilitates informal discussions and patient inclusivity. We now have agreed a policy to fund PRPs extra nights before and after meetings, and to bring a carer if needed.Enabling understanding– Future annual meetings will start with a F2F meeting between PRPs and Work Package Leads. Researchers will be encouraged to start presentations with a summary slide in lay language. Additionally, an RTCure Glossary is in development.Enabling participation– SK will provide monthly project updates and PRP TCs will be held in the evening (as some PRPs remain employed). PRPs will be invited to all project TCs and F2F meetings. Recruitment is underway to increase the number of ‘at risk’ PRPs as their viewpoint is vital to this study.Conclusion:Currently PPI in RTCure is an ongoing mutual learning process. Universal guidance regarding what types of contracts are needed for PPI would be useful. Communication, trust and fruitful discussions have evolved through F2F meetings (both formal and informal) between PRPs, academia and industry. It is important that all parties can be open with each other in order to make PPI more meaningful.Acknowledgments:This work has received support from the EU/EFPIA Innovative Medicines Initiative 2 Joint Undertaking RTCure grant number 777357.Disclosure of Interests:Savia de Souza: None declared, Ruth Williams: None declared, Eva Johansson: None declared, Codruta Zabalan: None declared, Tom Esterine: None declared, Margôt Bakkers: None declared, Wolfgang Roth: None declared, Neil Mc Carthy: None declared, Meryll Blake: None declared, Susanne Karlfeldt: None declared, Martina Johannesson: None declared, Karim Raza Grant/research support from: KR has received research funding from AbbVie and Pfizer, Consultant of: KR has received honoraria and/or consultancy fees from AbbVie, Sanofi, Lilly, Bristol-Myers Squibb, UCB, Pfizer, Janssen and Roche Chugai, Speakers bureau: KR has received honoraria and/or consultancy fees from AbbVie, Sanofi, Lilly, Bristol-Myers Squibb, UCB, Pfizer, Janssen and Roche Chugai

scholarly journals Discrepancies in reported versus measured nicotine content of e-cigarette refill liquids across nine European countries before and after the implementation of the EU Tobacco Products Directive

2019 ◽  
Vol 55 (2) ◽  
pp. 1900941 ◽  
Author(s):  
Charis Girvalaki ◽  
Manolis Tzatzarakis ◽  
Alexander Vardavas ◽  
Christina N. Kyriakos ◽  
Katerina Nikitara ◽  
...  
Keyword(s):  
European Countries ◽  
Tobacco Products ◽  
Nicotine Content ◽  
Before And After ◽  
The Eu
Sign in / Sign up

Export Citation Format

Share Document